Cannabinoid system in the skin - a possible target for future therapies in dermatology.
Cannabinoids and their derivatives are group of more than 60 biologically active chemical agents, which have been used in natural medicine for centuries. The major agent of exogenous cannabinoids is Delta(9)-tetrahydrocannabinol (Delta(9)-THC), natural psychoactive ingredient of marijuana. However, psychoactive properties of these substances limited their use as approved medicines. Recent discoveries of endogenous cannabinoids (e.g. arachidonoylethanolamide, 2-arachidonoylglycerol or palmithyloethanolamide) and their receptors initiated discussion on the role of cannabinoid system in physiological conditions as well as in various diseases. Based on the current knowledge, it could be stated that cannabinoids are important mediators in the skin, however their role have not been well elucidated yet. In our review, we summarized the current knowledge about the significant role of the cannabinoid system in the cutaneous physiology and pathology, pointing out possible future therapeutic targets.
Kupczyk
Piotr
P
Department of Clinical Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
Reich
Adam
A
Szepietowski
Jacek C
JC
D000818:Animals; D063385:Cannabinoid Receptor Modulators / Q000378:metabolism / Q000627:therapeutic use; D002186:Cannabinoids / Q000378:metabolism* / Q000627:therapeutic use; D002626:Chemistry, Pharmaceutical / Q000379:methods; D003880:Dermatology / Q000379:methods*; D015195:Drug Design; D006801:Humans; D007107:Immune System; D015603:Keratinocytes / Q000166:cytology; D008954:Models, Biological; D008956:Models, Chemical; D015398:Signal Transduction; D012867:Skin / Q000378:metabolism* / Q000503:physiopathology; D012871:Skin Diseases / Q000628:therapy*
D063385:Cannabinoid Receptor Modulators; D002186:Cannabinoids